MUT-TP53: A versatile matrix for TP53 mutation verification and publication

Human Mutation

Volumn 27, Issue 11, 2006, Pages 1151-1154

  Soussi, Thierry ^a,b   Rubio Nevado, Jean Michel ^a   Ishioka, Chikashi ^c  

^a SORBONNE UNIVERSITÉ   (France)

^b KAROLINSKA INSTITUTE   (Sweden)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CODON; GENE MUTATION; GENETIC ANALYSIS; INTERNET; LETTER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

DATABASES, GENETIC; DNA MUTATIONAL ANALYSIS; HUMANS; MUTATION; PUBLISHING; SENSITIVITY AND SPECIFICITY; SOFTWARE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33750896639     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20395     Document Type: Letter

References (12)

1. Bitton A, Neuman MD, Barnoya J, Glantz SA. 2005. The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest. Lancet 365:531-540.
2. den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12.
3. Gao HG, Chen JK, Stewart J, Song B, Rayappa C, Whong WZ, Ong T. 1997. Distribution of p53 and K-ras mutations in human lung cancer tissues. Carcinogenesis 18:473-478.
4. Hamroun D, Kato S, Ishioka C, Claustres M, Beroud C, Soussi T. 2006. The UMD TP53 database and website: update and revisions. Hum Mutat 27:14-20.
5. Horaitis O, Cotton RG. 2004. The challenge of documenting mutation across the genome: the human genome variation society approach. Hum Mutat 23:447-452.
6. Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C. 2003. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 100:8424-8429.
7. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. 2002. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607-614.
8. Olivier M, Hussain SP, Caron de Fromentel C, Hainaut P, Harris CC. 2004. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ 157:247-270.
9. Soussi T, Béroud C. 2001. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1:233-240.
10. Soussi T, Béroud C. 2003. Significance of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides. Hum Mutat 21:192-200.
11. Soussi T, Kato S, Levy PP, Ishioka C. 2005. Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum Mutat 25:6-17.
12. Soussi T, Asselain B, Hamroun D, Kato S, Ishioka C, Claustres M, Beroud C. 2006. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin Cancer Res 12:62-69.